IKKβ/NF-
B and the miscreant macrophage
Anjuli M. Timmer, and
Victor Nizet
A.M. Timmer and V. Nizet are at Department of Pediatrics, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093
CORRESPONDENCE V.N.: vnizet{at}ucsd.edu
Abstract:
Macrophage activation relies on complex intracellular signaling processes that integrate the need for rapid inflammatory responses to pathogens with the need to resolve inflammation without permanent harm to normal tissues. Patterns of aberrant macrophage activation characterize and sustain disorders of chronic inflammation, infection, and cancer. New studies now show a role for the NF-
B activator IKKβ in promoting an alternative, immunosuppressive pattern of macrophage activation, which limits the cell's tumoricidal and bactericidal capacities. As cancers and pathogens may have evolved multiple mechanisms to manipulate macrophages for their own survival, is there anything we can do about it?
© 2008 Timmer and Nizet This article is distributed under
the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months
after the publication date (see
http://www.jgp.org/misc/terms.shtml).
After six months it is available under a Creative Commons License
(Attribution–Noncommercial–Share Alike 3.0 Unported
license, as described at
http://creativecommons.org/licenses/by-nc-sa/3.0/).